MedTrace Logo

Administration of L. Paracasei 28.4 as an Adjunct to the Treatment of Periodontitis

NCT05107622 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-10-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the effects of probiotic administration of L. paracasei 28.4 as an adjunct to the non-surgical periodontal treatment in patients with periodontitis.

Conditions

  • Periodontitis

Interventions

OTHER

FMUD+Probiotic

Full-mouth ultrasonic periodontal debridement associated with administration of probiotic formulation (Lactobacillus paracasei 28.4) twice a day for 30 days.

OTHER

FMUD+Placebo

Full-mouth ultrasonic periodontal debridement associated with administration of placebo formulation twice a day for 30 days.

Sponsors & Collaborators

  • Universidade Estadual Paulista Júlio de Mesquita Filho

    lead OTHER

Principal Investigators

  • Laís F Ferraz, MS · Sao Paulo State University - Brazil

  • Mauro P Santamaria, PhD · Sao Paulo State University - Brazil

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2023-12-31
Completion
2024-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05107622 on ClinicalTrials.gov